 Will My Company’s Real Market Please Stand Up? Friday, October 16, 2009 8:30am to 11:00am 8:30 - Registration and Continental Breakfast 9:00 - 11:00 - Presentation, Q&A & Networking Citizens Bank Gateway Center 3025 Chemical Road Plymouth Meeting, PA 19462 Because all companies – large and small – play to two principal audiences: 1) their customers and 2) their investors. Chief among your investors’ principle concerns will be how savvy you are about identifying and targeting your specific market segment. We’ll deal with a number of key questions: * Has management gone out into in the marketplace to determine customer interest? * Have the sales projections been made from the bottom up? * Does the company / product have an unfair competitive advantage / proprietary technology? * Does management have respect for the competition, including an understanding of who brings what competitive threats to the table? * Where’s the competitive matrix? Is there a segmented market target? Are the company’s pricing and COG realistic / competitive? * Who will pay, and is there existing reimbursement? * Does everybody have a clear picture of what the playing field looks like, and is everybody agreed on how to attack the market? * How your company’s management team packages the science, the IP, your regulatory strategy and your exit strategy together with your go-to-market sense and sensibilities is critical to getting the funding you’ll need. Moderator: H. Donlon Skerrett, President, PCCI (Pharmaceutical Consulting Consortium International) Panelists: Michael D. Becker President and Chief Executive Officer MD Becker Partners LLC Joseph Zindulis, Ph.D. Former Director, Worldwide Sales & Marketing at GrantAdler Michele A. Zujkowski Venture Consultant Event scheduled: Oct 16 2009 |
 |
|||
Nurturing early-stage and emerging life science companies
